SIIC Capital

SIIC Capital is the private equity and fund management platform of SIIC Group, established to manage and deploy capital across strategic emerging industries. In healthcare, it is active through funds such as Shanghai Healthcare Capital, the Shanghai Healthcare M&A Fund, and the Hong Kong Biotechnology Fund, investing in early-stage, growth-stage, and strategic healthcare and biotech opportunities. The firm is not a drug developer and does not appear to operate its own therapeutic pipeline; instead, it backs biotech, medtech, and healthcare companies through investment, incubation, commercialization support, and industrial ecosystem development. SIIC Capital is based in Shanghai, has operations connected to Hong Kong, and is positioned as a state-backed, professionally operated investment platform with a strong focus on biomedicine and broader health-related innovation.